KAH Enzyme Variants for Efficient Steviol Conversion in Yeast
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The production of Reb M, a high-potency sweetener derived from the stevia plant, is impractical due to its low natural abundance, necessitating the development of efficient enzymatic pathways in microorganisms for large-scale synthesis.
Innovation Solution
Engineering variant kaurenoic acid hydroxylases (KAHs) to enhance the conversion of kaurenoic acid to steviol, utilizing host cells with specific amino acid substitutions to improve enzymatic efficiency and yield of Reb M.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If wild-type KAH enzyme is used, then the enzymatic step performs poorly in yeast, but the device complexity and manufacturing precision are not compromised
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of the KAH enzyme through site-directed mutagenesis. Specific residues were mutated to alter the enzyme's properties, resulting in variants with significantly improved conversion efficiency (up to 3.5-fold increase) and reliability in yeast hosts compared to the wild-type enzyme.
2Quantity of substance
If natural extraction of Reb M from stevia plant is performed, then the product is obtained, but the quantity produced is only minute fractions of total steviol glycoside content
Solution Approach 1:
The patent replaces the mechanical extraction process from stevia plants with a biological synthesis system using engineered yeast. By substituting plant-based extraction with microbial fermentation, the system achieves high-yield production of Reb M (up to 3.5-fold improvement in conversion efficiency) from sustainable feedstock, making the manufacturing process both practical and scalable.
Solution Approach 2:
The patent changes the biochemical parameters of the production system by introducing engineered KAH variants with optimized amino acid sequences. These parameter changes in enzyme efficiency translate to dramatically improved Reb M yield, converting a minute natural product into a high-volume fermentation product.
3Productivity
If wild-type enzymes are used in the bioconversion pathway, then the process is simple, but the conversion efficiency does not exceed 90% at each step
Solution Approach 1:
The patent systematically changes the amino acid parameters of KAH through rational design and site-directed mutagenesis. By identifying and mutating specific residues that affect catalytic activity and stability, the approach achieves >90% conversion efficiency while maintaining manageable engineering complexity through targeted rather than random modifications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered KAHs achieve high-efficiency conversion of kaurenoic acid to steviol, enabling the production of Reb M in significant quantities, addressing the impracticality of natural extraction.
Implementation Method 1
kaurenoic acid hydroxylase (KAH) which catalyzes the conversion of ent-kaurenoic acid into steviol
Implementation Method 2
KAHs that are capable of converting kaurenoic acid to steviol with high efficiency
Data Source
AI summary
Provided herein are genetically modified host cells, compositions, and methods for improved production of steviol glycosides. The host cells are genetically modified to contain a heterologous nucleic acid that expresses novel and optimized variants of Ro.KAH. The host cell further contains one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing one or more steviol glycosides in the host cell. The host cells, compositions, and methods described herein provide an efficient route for the heterologous production of steviol glycosides including rebaudioside A, rebaudioside D, and rebaudioside M.